Official sourceciencia-salud

WHO publishes target product profile for Bundibugyo virus disease vaccines

The document sets desired characteristics for vaccines that could support outbreak response and preparedness.

Abstract health image with pulse line and medical cross geometry. — Health - editorial illustration generated by NeuroStudio World Brief. It is not a photograph of the event. Credit: NeuroStudio World Brief. License: Original editorial asset. Internal site use permitted.

Editorial translation from the original Spanish article. Reviewed before publication.

Broad summary: WHO published a target product profile for vaccines against Bundibugyo virus disease. The document does not approve a vaccine; it defines what developers, regulators and funders should aim for. What happened: The profile outlines intended public-health use, including outbreak response and preparedness for at-risk populations. What is confirmed: WHO also continues to track a Bundibugyo outbreak in the Democratic Republic of the Congo and Uganda. What remains uncertain: Candidate timelines, trial results, approvals and real-world access remain open. Why it matters: A clear target profile can align research in an outbreak where specific vaccine tools are still limited.

Localization notes

English localized edition based on WHO documents and the Spanish article.